Frederick G Vogt insider trades
Open-market stock purchases and sales by Frederick G Vogt, Interim CEO & General Counsel at Iovance Biotherapeutics, Inc, from SEC Form 4 filings since Dec 29, 2017.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 5, 2026 | IOVA Iovance Biotherapeutics, Inc | Sold (not open market) | $28.1K |
| Jun 5, 2026 | IOVA Iovance Biotherapeutics, Inc | Bought (not open market) | — |
| Jun 1, 2026 | IOVA Iovance Biotherapeutics, Inc | Sold (not open market) | $70.1K |
| Jun 1, 2026 | IOVA Iovance Biotherapeutics, Inc | Bought (not open market) | — |
| Mar 9, 2026 | IOVA Iovance Biotherapeutics, Inc | Bought (not open market) | — |
| Mar 5, 2026 | IOVA Iovance Biotherapeutics, Inc | Sold (not open market) | $123K |
| Mar 5, 2026 | IOVA Iovance Biotherapeutics, Inc | Bought (not open market) | — |
| Mar 2, 2026 | IOVA Iovance Biotherapeutics, Inc | Bought (not open market) | — |
| Mar 2, 2026 | IOVA Iovance Biotherapeutics, Inc | Sold (not open market) | $86.4K |
| Mar 2, 2026 | IOVA Iovance Biotherapeutics, Inc | Bought (not open market) | — |
| Mar 2, 2026 | IOVA Iovance Biotherapeutics, Inc | Bought (not open market) | — |
| Dec 2, 2025 | IOVA Iovance Biotherapeutics, Inc | Sold (not open market) | $9.5K |
| Dec 2, 2025 | IOVA Iovance Biotherapeutics, Inc | Bought (not open market) | — |
| Dec 1, 2025 | IOVA Iovance Biotherapeutics, Inc | Sold (not open market) | $39.5K |
| Dec 1, 2025 | IOVA Iovance Biotherapeutics, Inc | Bought (not open market) | — |
Companies traded
- IOVA Iovance Biotherapeutics, Inc: 3 buys, last Jun 5, 2026